About Us
Fosen Pharmaceutical Limited is an indigenous pharmaceutical company established on 16th May, 2018, with corporate office at Lagos Nigeria. It is registered under Corporate Affairs Commissions of Nigeria (CAC), and duly registered with Pharmacist Council of Nigeria (PCN), Pharmaceuticals Society of Nigeria (PSN), and Association of Industrial Pharmacist of Nigeria (NAIP). Fosen is hundred percent (100%) compliance with all regulations of National Food and Drugs Agency Commissions (NAFDAC) in all her operations. The company has introduced four products - Formal QS, Senvite Tonic, Senclavin 625mg, and Senpro 500mg into the Nigeria Pharmaceutical market. Fosen Pharmaceuticals Limited is dedicated to filling the emerging pharmaceutical needs of consumers, towards improving community and global healthcare. Fosen maintains a strong commitment to research and development, focuses on creating cutting-edge pharmaceuticals solutions that address a wide range of pharmaceutical needs.
More About
Fosen Pharmaceutical
The company pay high regard to the guidelines of regulatory authorities; to ensure that all products are manufactured and marketed under strict compliance with regulatory provisions of the controlling authorities in the pharmaceutical sector. At Fosen Pharmaceutical Limited, we prioritize consumers’ safety, health; and strive to make a positive impact on the well-being of consumers in our products coverage areas.
Our unwavering dedication to excellence and innovation drives us to push the boundaries of scientific discovery and bring life-changing solutions to people in need. We are proud to be a trusted partner in healthcare sector; and are committed to shaping a healthier future for all.
Our History
The evolution of our pharmaceutical company’s manufacturing history has been marked by significant advancements in the production of essential medications like malaria treatments, ciprofloxacin, amoxicillin and blood tonics.
We began our journey by focusing on researching and developing effective formulations to combat malaria, a disease that affects millions around the world. Our commitment to innovation led us to refine the manufacturing processes, ensuring high-quality medications that are both safe and efficient in treating malaria.
Expanding our product line, we ventured into the production of ciprofloxacin, a powerful antibiotics used to treat a wide range of bacterial infections. Though stringent quality control measures and continuous improvement in manufacturing techniques, we have been able to meet the growing demands for this critical medication.
In recognition of the importance of maintaining healthy blood levels, we introduced a blood tonic to our repertoire of pharmaceutical products. Our dedication to precision in manufacturing and adherence to regulatory standards have ensured the potency and effectiveness of our blood tonic in addressing deficiencies and promoting overall well-being.
Over the years, our pharmaceutical company has built a strong foundation based on a commitment to quality, innovation and excellence in manufacturing. By prioritizing research and development, investing in cutting-edge technologies and upholding the highest standards of production, we continue to play a vital role in filling the emerging consumer’s needs and providing essential medications to improve the health and well-being of individuals worldwide.
Our Team
Oseni
Chairman
Chief Executive Officer
Akinwale
Lagos and West
Sales Cordinator
(B.Pharm/MPCN/MPSN/ M.Pharm)
Director of Pharmacy
Igwilo
B.Pharm, MPCN, MPSN
Senior Pharmacist